This screen was conducted on parental H358 NSCLC cells (KRAS-G12C mutation) and their G12Ci-resistant derivatives (KRAS-G12C/NRAS-Q61K double mutation) (14). This evidence concerns the gene KRAS and non-small cell lung carcinoma.